Accéder au contenu
Merck
Toutes les photos(1)

Documents

G3295-4

Sigma-Aldrich

ProtaSea® Fucoidan

brown seaweed extract

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Code UNSPSC :
12352201
Nomenclature NACRES :
NA.25

Niveau de qualité

100

Forme

powder

pH

5.5-8.5 (20 °C, 1% in water)

Viscosité

5-10 mPa.s

Application

NovaMatrix ProtaSea fucoidan is a brown seaweed extract from Laminaria Hyperborea. The product is manufactured in Norway from fresh seaweed sources, using natural extraction techniques. This allows ProtaSea fucoidans to be as close as possible to their natural state. Novamatrix ProtaSea fucoidan is 80% fucose. ProtaSea fucoidans can be used in personal care and nutraceutical products. ProtaSea fucoidans can potentially be used in drug therapy research, joint health, immune health, anti-inflammatory therapies, medical device coating, etc.

Informations légales

Product of Dupont Nutrition USA, Inc.
PROTASEA is a registered trademark of DuPont Nutrition USA, Inc.

Clause de non-responsabilité

NOT FOR USE IN HUMANS

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Articles

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Rational Design of ECMs Toward Cancer Immunotherapy

Engineered ECMs enhance immune therapy in cancer treatment by supporting cells and tissues and modulating immune response. They improve immune cell maturation, expansion, and regulation through biomaterial manipulation, acting as frameworks or carriers for enhanced tumor immunotherapy.

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique